Hans-Peter Beck researcher
Beck, Hans Peter 1941-
Beck, Hans Peter
VIAF ID: 65098167 (Personal)
Permalink: http://viaf.org/viaf/65098167
Preferred Forms
- 100 1 _ ‡a Beck, Hans Peter
- 100 1 _ ‡a Beck, Hans Peter ‡d 1941-
- 100 1 _ ‡a Beck, Hans Peter ‡d 1941-
- 100 0 _ ‡a Hans-Peter Beck ‡c researcher
4xx's: Alternate Name Forms (2)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
The Economics of Big Science : Essays by Leading Scientists and Policymakers | |
The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials. II. Mortality and morbidity. | |
The epidemiology of multiple Plasmodium falciparum infections. 1. General introduction | |
etramps, a new Plasmodium falciparum gene family coding for developmentally regulated and highly charged membrane proteins located at the parasite-host cell interface | |
Evidence for limited activation of distinct CD4+ T cell subsets in response to the Plasmodium falciparum circumsporozoite protein in Papua New Guinea. | |
Evolution of Pacific/Asian populations inferred from HLA class II allele frequency distributions | |
Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage | |
Genetic diversity of expressed Plasmodium falciparum var genes from Tanzanian children with severe malaria | |
Genomic distribution and functional characterisation of two distinct and conserved Plasmodium falciparum var gene 5' flanking sequences | |
Das gesetzliche Gewinnanteilsrecht der Miterben : Die revidierten Art. 619 ff. ZGB und die ausländischen Regelungen | |
Hemozoin-catalyzed precipitation polymerization as an assay for malaria diagnosis | |
Heritability and segregation analysis of immune responses to specific malaria antigens in Papua New Guinea | |
Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains | |
Identification and differentiation of Leishmania species in clinical samples by PCR amplification of the miniexon sequence and subsequent restriction fragment length polymorphism analysis | |
Identification of nuclear proteins that interact differentially with Plasmodium falciparum var gene promoters | |
Das Ingenieurwissen: Elektrotechnik | |
Lack of multiple copies of pfmdr1 gene in Papua New Guinea | |
Longitudinal assessment of Plasmodium falciparum var gene transcription in naturally infected asymptomatic children in Papua New Guinea | |
MAHRP-1, a novel Plasmodium falciparum histidine-rich protein, binds ferriprotoporphyrin IX and localizes to the Maurer's clefts | |
Malaria infection and morbidity in infants in relation to genetic polymorphisms in Tanzania | |
The Maurer's cleft protein MAHRP1 is essential for trafficking of PfEMP1 to the surface of Plasmodium falciparum-infected erythrocytes | |
A microarray-based system for the simultaneous analysis of single nucleotide polymorphisms in human genes involved in the metabolism of anti-malarial drugs | |
Modifications cellulaires et moléculaires induites par l'agent du paludisme Plasmodium falciparum dans le globule rouge humain parasité = Molecular and cellular aspects of the modifications induced by the human malaria parasite Plasmodium falciparum in the infected red blood cells | |
Molecular approaches to diversity of populations of apicomplexan parasites | |
Molecular approaches to epidemiology and clinical aspects of malaria. | |
Molecular assays for antimalarial drug resistance surveillance: A target product profile | |
Molecular Diagnosis of Infectious Diseases | |
Molecular genotyping in a malaria treatment trial in Uganda - unexpected high rate of new infections within 2 weeks after treatment | |
Monitoring of malaria parasite resistance to chloroquine and sulphadoxine-pyrimethamine in the Solomon Islands by DNA microarray technology | |
Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages | |
Nanomimics of host cell membranes block invasion and expose invasive malaria parasites | |
Novel genotyping tools for investigating transmission dynamics of Plasmodium falciparum | |
Organization of ETRAMPs and EXP-1 at the parasite-host cell interface of malaria parasites. | |
PCR amplification of DNA from malaria parasites on fixed and stained thick and thin blood films. | |
The PHIST protein GEXP02 targets the host cytoskeleton during sexual development of Plasmodium falciparum | |
Plasmodium falciparum: cloned and expressed CIDR domains of PfEMP1 bind to chondroitin sulfate A. | |
Plasmodium falciparum: expression of gametocyte-specific genes in monolayer cultures and malaria-positive blood samples | |
Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea | |
Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa | |
Plasmodium falciparum Plasmodium helical interspersed subtelomeric proteins contribute to cytoadherence and anchor P. falciparum erythrocyte membrane protein 1 to the host cell cytoskeleton | |
Plasmodium falciparum possesses a cell cycle-regulated short type replication protein A large subunit encoded by an unusual transcript | |
Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance | |
Plasmodium sensitivity to artemisinins: magic bullets hit elusive targets | |
A point mutation in codon 76 of pfcrt of P. falciparum is positively selected for by Chloroquine treatment in Tanzania | |
Quantifying the evolution and impact of antimalarial drug resistance: drug use, spread of resistance, and drug failure over a 12-year period in Papua New Guinea | |
Rapid DNA extraction for molecular epidemiological studies of malaria. | |
Rapid microarray-based method for monitoring of all currently known single-nucleotide polymorphisms associated with parasite resistance to antimalaria drugs | |
Relationships between Plasmodium falciparum infection and morbidity in a highly endemic area | |
Residual antimalarials in malaria patients from Tanzania--implications on drug efficacy assessment and spread of parasite resistance | |
RFLP analysis | |
Rôle des phosphatases au cours du cycle érythrocytaire du parasite responsable du paludisme humain Plasmodium falciparum.. | |
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children | |
Screen test | |
Sequence and expression of a gene from Theileria annulata coding for a 70-kilodalton heat-shock protein. | |
Sequence diversity and molecular evolution of the merozoite surface antigen 2 of Plasmodium falciparum. | |
Spiroindolones, a potent compound class for the treatment of malaria | |
Strain-specific humoral response to a polymorphic malaria vaccine | |
Strategies for detection of Plasmodium species gametocytes | |
Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in v | |
Tuberculosis in Papua New Guinea: from yesterday until today | |
The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment | |
The use of the polymerase chain reaction for more sensitive detection of Plasmodium falciparum. | |
The use of untreated bednets and malaria infection, morbidity and immunity | |
The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea | |
Virulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case-control study |